FindTrial
Sign In

Analysis of Peripheral Blood GDF-15 and Novel Serum-Derived Biomarker Expression in Coronary Heart Disease Patients at Different Glycometabolic Levels, Along with Cardiovascular Risk Factors and Coronary Artery Lesion Characteristics

Analysis of Peripheral Blood GDF-15 and Novel Serum-Derived Biomarker Expression in Coronary Heart Disease Patients at Different Glycometabolic Levels, Along with Cardiovascular Risk Factors and Coronary Artery Lesion Characteristics

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600116347
Enrollment
Unknown
Registered
2026-01-08
Start date
2026-01-10
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

CHD

Interventions

MACEs group:none
Non-MACEs group:none

Sponsors

Northern Jiangsu People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. Age 18 to 90 years; 2.Diagnosed with coronary heart disease; 3. Complete clinical records.

Exclusion criteria

Exclusion criteria: 1. Significant impairment of hepatic or renal function (liver transaminases exceeding three times the upper limit of normal or end-stage chronic kidney disease with glomerular filtration rate <30 mL/min); 2. History of cardiac surgery, severe cardiovascular or respiratory disease (NYHA Class III-IV heart failure, cardiogenic shock, or respiratory failure); 3. Severe diseases in other systems (e.g., hyperthyroidism, active infections, malignant tumors, autoimmune diseases, or hematological disorders); 4. Participants lost to follow-up.

Design outcomes

Primary

MeasureTime frame
GDF-15;—

Countries

China

Contacts

Public ContactJing Zhang

Northern Jiangsu People's Hospital

zhangjingyjs@163.com+86 159 5273 9006

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026